Global Veterinary-Animal Vaccines Market Trend and Development Strategy Analysis 2023-2029
Market Analysis and Insights: Global Veterinary-Animal Vaccines Market
The global Veterinary-Animal Vaccines market size in 2022 is 10690.0 million US dollars, and it is expected to be XX million US dollars by 2029, with a compound annual growth rate of 6.90% expected in 2023-2029.
MARKET COMPETITIVE LANDSCAPE:
The main players in the Veterinary-Animal Vaccines market include Bayer AG (Germany), Sanofi (France), Pfizer Inc. (U.S.), GSK plc (U.K.), and Merck & Co., Inc. (U.S.). The share of the top 3 players in the Veterinary-Animal Vaccines market is XX%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Veterinary-Animal Vaccines market, and Asia Pacific accounted for XX%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. Live Attenuated Vaccines accounted for XX% of Veterinary-Animal Vaccines market in 2022. Inactivated Vaccines share of XX%.
Hospitals accounted for XX% of the Veterinary-Animal Vaccines market in 2022. Clinics accounts for XX%.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Veterinary-Animal Vaccines market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Veterinary-Animal Vaccines market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Veterinary-Animal Vaccines market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Veterinary-Animal Vaccines market.
Global Veterinary-Animal Vaccines Scope and Market Size
Veterinary-Animal Vaccines market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Veterinary-Animal Vaccines market will be able to gain the upper hand as they use the report as a powerful resource.
The impact of the outbreak of COVID-19 and the Russia-Ukraine War on the Veterinary-Animal Vaccines industry is considered in the report, covering the dynamic analysis of the development of the Veterinary-Animal Vaccines industry, including trends, technologies, opportunities, constraints. To ensure report buyers are able to gain in-depth knowledge of the market.
The life sciences industry grows and continues to advance, driving innovation and improving healthcare outcomes for individuals around the world.
Artificial Intelligence (AI) and Machine Learning (ML): AI and ML technologies are increasingly being employed in life sciences research and development. They aid in drug discovery, optimizing clinical trials, analyzing vast amounts of biological data, and identifying patterns that can lead to breakthroughs in understanding diseases and developing new therapies.
Digital Health Technologies: Digital health technologies have seen rapid growth, especially in areas like telemedicine, wearable devices, and mobile health applications. These technologies enable remote patient monitoring, facilitate better healthcare access, and empower individuals to manage their health more effectively.
Wearable Devices and Remote Monitoring: Wearable devices, such as smartwatches and fitness trackers, have become more sophisticated, enabling continuous monitoring of vital signs and health parameters. These devices offer opportunities for early detection of health issues and improved management of chronic conditions.
Market Data Breakdown by Regions
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Spain
Nordic
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
Egypt
South Africa
UAE
Turkey
Saudi Arabia
Some prominent players in the market includes:
Bayer AG (Germany)
Sanofi (France)
Pfizer Inc. (U.S.)
GSK plc (U.K.)
Merck & Co., Inc. (U.S.)
Ceva (France)
Cargill, Incorporated (U.S.)
Boehringer Ingelheim International GmbH. (Germany)
Takeda Pharmaceutical Company Limited (Japan)
Zoetis (U.S.)
Dechra Pharmaceuticals PLC (U.K.)
Hester Biosciences Limited. (India)
Elanco (U.S.)
Phibro Animal Health Corporation (U.S.)
Indovax (India)
Market Data Breakdown by Type
Live Attenuated Vaccines
Inactivated Vaccines
Toxoid Vaccines
Recombinant Vaccines
Other Vaccines
Market Data Breakdown by Applications
Hospitals
Clinics
Table of Content
1 Veterinary-Animal Vaccines Market Introduction and Overview
1.1 Veterinary-Animal Vaccines Definition
1.2 Research Purposes
1.3 Report Timeline
1.4 Economic Analysis of Global Regions
1.5 Veterinary-Animal Vaccines Industry Dynamic Analysis
1.5.1 Veterinary-Animal Vaccines Market Trends Analysis
1.5.2 Veterinary-Animal Vaccines Market Drivers Analysis
1.5.3 Veterinary-Animal Vaccines Market Challenges Analysis
1.5.4 Veterinary-Animal Vaccines Market Restraints Analysis
1.6 Inflation Analysis
1.7 The Impact of the Russian-Ukrainian War on the Market
1.8 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Global Veterinary-Animal Vaccines Market Insights by Type
2.1 Market Size Insights by Types
2.2 Global Veterinary-Animal Vaccines Revenue and Share by Type
3 Global Veterinary-Animal Vaccines Market Insights by Application
3.1 Market Size Insights by Application
3.2 Global Veterinary-Animal Vaccines Revenue and Share by Application (2018-2023)
4 Global Market Growth Insights
4.1 Global Veterinary-Animal Vaccines Market Size (2018-2023)
4.2 Veterinary-Animal Vaccines Growth Insights by Regions
4.2.1 Veterinary-Animal Vaccines Market Size by Regions: 2018 VS 2023 VS 2029
4.2.2 Veterinary-Animal Vaccines Revenue Market Size by Regions (2018-2023)
4.2.3 North America Veterinary-Animal Vaccines Market Size (2018-2023)
4.2.4 Europe Veterinary-Animal Vaccines Market Size (2018-2023)
4.2.5 Asia-Pacific Veterinary-Animal Vaccines Market Size (2018-2023)
4.2.6 Latin America Veterinary-Animal Vaccines Market Size (2018-2023)
4.2.7 Middle East & Africa Veterinary-Animal Vaccines Market Size (2018-2023)
5 North America
5.1 North America Veterinary-Animal Vaccines Revenue by Countries
5.1.1 North America Veterinary-Animal Vaccines Revenue by Countries (2018-2023)
5.2 North America PEST Analysis
5.3 United States
5.4 Canada
6 Asia Pacific
6.1 Asia Pacific Veterinary-Animal Vaccines Revenue by Countries
6.1.1 Asia Pacific Veterinary-Animal Vaccines Revenue by Countries (2018-2023)
6.2 Asia-Pacific PEST Analysis
6.3 China
6.4 Japan
6.5 Korea
6.6 Southeast Asia
6.7 India
6.8 Australia
7 Europe
7.1 Europe Veterinary-Animal Vaccines Revenue by Countries
7.1.1 Europe Veterinary-Animal Vaccines Revenue by Countries (2018-2023)
7.2 Europe PEST Analysis
7.3 Germany
7.4 France
7.5 UK
7.6 Italy
7.7 Russia
7.8 Spain
7.9 Nordic
8 Latin America
8.1 Latin America Veterinary-Animal Vaccines Revenue by Countries
8.1.1 Latin America Veterinary-Animal Vaccines Revenue by Countries (2018-2023)
8.2 Latin America PEST Analysis
8.3 Brazil
8.4 Argentina
8.5 Mexico
9 Middle East & Africa
9.1 Middle East & Africa Veterinary-Animal Vaccines Revenue by Countries
9.1.1 Middle East & Africa Veterinary-Animal Vaccines Revenue by Countries (2018-2023)
9.2 Middle East & Africa PEST Analysis
9.3 Egypt
9.4 South Africa
9.5 UAE
9.6 Turkey
9.7 Saudi Arabia
10 Global Veterinary-Animal Vaccines Market Competition, by Players
10.1 Global Veterinary-Animal Vaccines Revenue and Market Share by Players
10.2 Market Concentration Rate
10.2.1 Top 3 Veterinary-Animal Vaccines Players Market Share in 2022
10.2.2 Top 6 Veterinary-Animal Vaccines Players Market Share in 2022
10.2.3 Market Competition Trend
10.3 Veterinary-Animal Vaccines Players Head Office, Business Provided
10.4 Veterinary-Animal Vaccines Mergers & Acquisitions
10.5 Veterinary-Animal Vaccines New Entrants and Expansion Plans
11 Players Profiles
11.1 Bayer AG (Germany)
11.1.1 Bayer AG (Germany) Company Profile
11.1.2 Veterinary-Animal Vaccines Product Overview
11.1.3 Bayer AG (Germany) Veterinary-Animal Vaccines Market Performance (2018-2023)
11.1.4 Bayer AG (Germany) Business Overview
11.1.5 Recent Developments and Plans
11.2 Sanofi (France)
11.2.1 Sanofi (France) Company Profile
11.2.2 Veterinary-Animal Vaccines Product Overview
11.2.3 Sanofi (France) Veterinary-Animal Vaccines Market Performance (2018-2023)
11.2.4 Sanofi (France) Business Overview
11.2.5 Recent Developments and Plans
11.3 Pfizer Inc. (U.S.)
11.3.1 Pfizer Inc. (U.S.) Company Profile
11.3.2 Veterinary-Animal Vaccines Product Overview
11.3.3 Pfizer Inc. (U.S.) Veterinary-Animal Vaccines Market Performance (2018-2023)
11.3.4 Pfizer Inc. (U.S.) Business Overview
11.3.5 Recent Developments and Plans
11.4 GSK plc (U.K.)
11.4.1 GSK plc (U.K.) Company Profile
11.4.2 Veterinary-Animal Vaccines Product Overview
11.4.3 GSK plc (U.K.) Veterinary-Animal Vaccines Market Performance (2018-2023)
11.4.4 GSK plc (U.K.) Business Overview
11.4.5 Recent Developments and Plans
11.5 Merck & Co., Inc. (U.S.)
11.5.1 Merck & Co., Inc. (U.S.) Company Profile
11.5.2 Veterinary-Animal Vaccines Product Overview
11.5.3 Merck & Co., Inc. (U.S.) Veterinary-Animal Vaccines Market Performance (2018-2023)
11.5.4 Merck & Co., Inc. (U.S.) Business Overview
11.5.5 Recent Developments and Plans
11.6 Ceva (France)
11.6.1 Ceva (France) Company Profile
11.6.2 Veterinary-Animal Vaccines Product Overview
11.6.3 Ceva (France) Veterinary-Animal Vaccines Market Performance (2018-2023)
11.6.4 Ceva (France) Business Overview
11.6.5 Recent Developments and Plans
11.7 Cargill, Incorporated (U.S.)
11.7.1 Cargill, Incorporated (U.S.) Company Profile
11.7.2 Veterinary-Animal Vaccines Product Overview
11.7.3 Cargill, Incorporated (U.S.) Veterinary-Animal Vaccines Market Performance (2018-2023)
11.7.4 Cargill, Incorporated (U.S.) Business Overview
11.7.5 Recent Developments and Plans
11.8 Boehringer Ingelheim International GmbH. (Germany)
11.8.1 Boehringer Ingelheim International GmbH. (Germany) Company Profile
11.8.2 Veterinary-Animal Vaccines Product Overview
11.8.3 Boehringer Ingelheim International GmbH. (Germany) Veterinary-Animal Vaccines Market Performance (2018-2023)
11.8.4 Boehringer Ingelheim International GmbH. (Germany) Business Overview
11.8.5 Recent Developments and Plans
11.9 Takeda Pharmaceutical Company Limited (Japan)
11.9.1 Takeda Pharmaceutical Company Limited (Japan) Company Profile
11.9.2 Veterinary-Animal Vaccines Product Overview
11.9.3 Takeda Pharmaceutical Company Limited (Japan) Veterinary-Animal Vaccines Market Performance (2018-2023)
11.9.4 Takeda Pharmaceutical Company Limited (Japan) Business Overview
11.9.5 Recent Developments and Plans
11.10 Zoetis (U.S.)
11.10.1 Zoetis (U.S.) Company Profile
11.10.2 Veterinary-Animal Vaccines Product Overview
11.10.3 Zoetis (U.S.) Veterinary-Animal Vaccines Market Performance (2018-2023)
11.10.4 Zoetis (U.S.) Business Overview
11.10.5 Recent Developments and Plans
11.11 Dechra Pharmaceuticals PLC (U.K.)
11.11.1 Dechra Pharmaceuticals PLC (U.K.) Company Profile
11.11.2 Veterinary-Animal Vaccines Product Overview
11.11.3 Dechra Pharmaceuticals PLC (U.K.) Veterinary-Animal Vaccines Market Performance (2018-2023)
11.11.4 Dechra Pharmaceuticals PLC (U.K.) Business Overview
11.11.5 Recent Developments and Plans
11.12 Hester Biosciences Limited. (India)
11.12.1 Hester Biosciences Limited. (India) Company Profile
11.12.2 Veterinary-Animal Vaccines Product Overview
11.12.3 Hester Biosciences Limited. (India) Veterinary-Animal Vaccines Market Performance (2018-2023)
11.12.4 Hester Biosciences Limited. (India) Business Overview
11.12.5 Recent Developments and Plans
11.13 Elanco (U.S.)
11.13.1 Elanco (U.S.) Company Profile
11.13.2 Veterinary-Animal Vaccines Product Overview
11.13.3 Elanco (U.S.) Veterinary-Animal Vaccines Market Performance (2018-2023)
11.13.4 Elanco (U.S.) Business Overview
11.13.5 Recent Developments and Plans
11.14 Phibro Animal Health Corporation (U.S.)
11.14.1 Phibro Animal Health Corporation (U.S.) Company Profile
11.14.2 Veterinary-Animal Vaccines Product Overview
11.14.3 Phibro Animal Health Corporation (U.S.) Veterinary-Animal Vaccines Market Performance (2018-2023)
11.14.4 Phibro Animal Health Corporation (U.S.) Business Overview
11.14.5 Recent Developments and Plans
11.15 Indovax (India)
11.15.1 Indovax (India) Company Profile
11.15.2 Veterinary-Animal Vaccines Product Overview
11.15.3 Indovax (India) Veterinary-Animal Vaccines Market Performance (2018-2023)
11.15.4 Indovax (India) Business Overview
11.15.5 Recent Developments and Plans
12 Global Veterinary-Animal Vaccines Forecast Market Insights by Type
12.1 Global Veterinary-Animal Vaccines Revenue Market Forecast by Type (2023-2029)
13 Global Veterinary-Animal Vaccines Forecast Market Insights by Application
13.1 Veterinary-Animal Vaccines Revenue Market Forecast by Application (2023-2029)
14 Global Market Growth Forecast Insights
14.1 Global Veterinary-Animal Vaccines Forecast Market Size (2023-2029)
14.2 Veterinary-Animal Vaccines Growth Forecast Insights by Regions
14.2.1 Veterinary-Animal Vaccines Revenue Forecast Market Size by Regions (2023-2029)
14.2.2 North America Veterinary-Animal Vaccines Forecast Market Size (2023-2029)
14.2.3 Europe Veterinary-Animal Vaccines Forecast Market Size (2023-2029)
14.2.4 Asia-Pacific Veterinary-Animal Vaccines Forecast Market Size (2023-2029)
14.2.5 Latin America Veterinary-Animal Vaccines Forecast Market Size (2023-2029)
14.2.6 Middle East & Africa Veterinary-Animal Vaccines Forecast Market Size (2023-2029)
15 Methodology and Data Source
15.1 A Methodology
15.1.1 Research Process
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 B Data Source
15.2.1 Legal Disclaimer
List of Tables and Figures
Figure Veterinary-Animal Vaccines Picture
Table Product Definition of Veterinary-Animal Vaccines
Table Economic Analysis of Global Regions
Table Market Trends Analysis
Table Market Drivers Analysis
Table Market Challenges Analysis
Table Market Restraints Analysis
Table Inflation Analysis
Table The Impact of the Russian-Ukrainian War on the Market
Figure 2020 (COVID-19) Impact on Global Economic Growth 2019, 2020, 2021
Figure Population infected by the Covid-19 of Major Countries
Table Global Veterinary-Animal Vaccines Market Size by Type (2018 VS 2023 VS 2029)
Table Global Veterinary-Animal Vaccines Revenue by Type (2018-2023)
Table Global Veterinary-Animal Vaccines Revenue and Share by Type (2018-2023)
Table Global Veterinary-Animal Vaccines Market Size by Application (2018 VS 2023 VS 2029)
Table Global Veterinary-Animal Vaccines Revenue by Application (2018-2023)
Table Global Veterinary-Animal Vaccines Revenue Share by Application (2018-2023)
Figure Global Veterinary-Animal Vaccines Revenue Market Size Growth (2018-2023)
Table Veterinary-Animal Vaccines Market Size by Regions: 2018 VS 2023 VS 2029
Table Veterinary-Animal Vaccines Revenue Market Size by Regions (2018-2023)
Table Veterinary-Animal Vaccines Revenue and Share by Regions (2018-2023)
Figure North America Veterinary-Animal Vaccines Market Size (2018-2023)
Figure Europe Veterinary-Animal Vaccines Market Size (2018-2023)
Figure Asia-Pacific Veterinary-Animal Vaccines Market Size (2018-2023)
Figure Latin America Veterinary-Animal Vaccines Market Size (2018-2023)
Figure Middle East & Africa Veterinary-Animal Vaccines Market Size (2018-2023)
Table North America Veterinary-Animal Vaccines Revenue by Countries (2018-2023)
Table North America Veterinary-Animal Vaccines Revenue and Share by Countries (2018-2023)
Table North America PEST Analysis
Figure United States Veterinary-Animal Vaccines Revenue and Growth (2018-2023)
Figure Canada Veterinary-Animal Vaccines Revenue and Growth (2018-2023)
Figure Canada Veterinary-Animal Vaccines Sales and Growth (2018-2023)
Table Asia-Pacific Veterinary-Animal Vaccines Revenue by Countries (2018-2023)
Table Asia-Pacific Veterinary-Animal Vaccines Revenue and Share by Countries (2018-2023)
Table Asia-Pacific PEST Analysis
Figure China Veterinary-Animal Vaccines Revenue and Growth (2018-2023)
Figure Japan Veterinary-Animal Vaccines Revenue and Growth (2018-2023)
Figure Korea Veterinary-Animal Vaccines Revenue and Growth (2018-2023)
Figure Southeast Asia Veterinary-Animal Vaccines Revenue and Growth (2018-2023)
Figure India Veterinary-Animal Vaccines Revenue and Growth (2018-2023)
Figure Australia Veterinary-Animal Vaccines Revenue and Growth (2018-2023)
Table Europe Veterinary-Animal Vaccines Revenue by Countries (2018-2023)
Table Europe Veterinary-Animal Vaccines Revenue and Share by Countries (2018-2023)
Table Europe PEST Analysis
Figure Germany Veterinary-Animal Vaccines Revenue and Growth (2018-2023)
Figure France Veterinary-Animal Vaccines Revenue and Growth (2018-2023)
Figure UK Veterinary-Animal Vaccines Revenue and Growth (2018-2023)
Figure Italy Veterinary-Animal Vaccines Revenue and Growth (2018-2023)
Figure Russia Veterinary-Animal Vaccines Revenue and Growth (2018-2023)
Figure Spain Veterinary-Animal Vaccines Revenue and Growth (2018-2023)
Figure Nordic Veterinary-Animal Vaccines Revenue and Growth (2018-2023)
Table Latin America Veterinary-Animal Vaccines Revenue by Countries (2018-2023)
Table Latin America Veterinary-Animal Vaccines Revenue and Share by Countries (2018-2023)
Table Latin America PEST Analysis
Figure Brazil Veterinary-Animal Vaccines Revenue and Growth (2018-2023)
Figure Argentina Veterinary-Animal Vaccines Revenue and Growth (2018-2023)
Figure Mexico Veterinary-Animal Vaccines Revenue and Growth (2018-2023)
Table Middle East & Africa Veterinary-Animal Vaccines Revenue by Countries (2018-2023)
Table Middle East & Africa Veterinary-Animal Vaccines Revenue and Share by Countries (2018-2023)
Table Middle East & Africa PEST Analysis
Figure Egypt Veterinary-Animal Vaccines Revenue and Growth (2018-2023)
Figure South Africa Veterinary-Animal Vaccines Revenue and Growth (2018-2023)
Figure UAE Veterinary-Animal Vaccines Revenue and Growth (2018-2023)
Figure Turkey Veterinary-Animal Vaccines Revenue and Growth (2018-2023)
Figure Saudi Arabia Veterinary-Animal Vaccines Revenue and Growth (2018-2023)
Table Global Veterinary-Animal Vaccines Revenue by Players (2018-2023)
Table Global Veterinary-Animal Vaccines Revenue Market Share by Players (2018-2023)
Figure Global Top 3 Companies Revenue Share in 2022
Figure Global Top 6 Companies Revenue Share in 2022
Table Global Veterinary-Animal Vaccines Players Market Concentration Ratio (CR5) (2018-2023)
Table Veterinary-Animal Vaccines Players Head Office, Business Provided
Table Mergers & Acquisitions
Table New Entrants and Expansion Plans
Table Bayer AG (Germany) Profile
Table Product Overview
Table Bayer AG (Germany) Veterinary-Animal Vaccines Revenue, Gross and Gross Margin (2018-2023)
Figure Bayer AG (Germany) Revenue and Growth Rate
Figure Bayer AG (Germany) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Sanofi (France) Profile
Table Product Overview
Table Sanofi (France) Veterinary-Animal Vaccines Revenue, Gross and Gross Margin (2018-2023)
Figure Sanofi (France) Revenue and Growth Rate
Figure Sanofi (France) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Pfizer Inc. (U.S.) Profile
Table Product Overview
Table Pfizer Inc. (U.S.) Veterinary-Animal Vaccines Revenue, Gross and Gross Margin (2018-2023)
Figure Pfizer Inc. (U.S.) Revenue and Growth Rate
Figure Pfizer Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table GSK plc (U.K.) Profile
Table Product Overview
Table GSK plc (U.K.) Veterinary-Animal Vaccines Revenue, Gross and Gross Margin (2018-2023)
Figure GSK plc (U.K.) Revenue and Growth Rate
Figure GSK plc (U.K.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Merck & Co., Inc. (U.S.) Profile
Table Product Overview
Table Merck & Co., Inc. (U.S.) Veterinary-Animal Vaccines Revenue, Gross and Gross Margin (2018-2023)
Figure Merck & Co., Inc. (U.S.) Revenue and Growth Rate
Figure Merck & Co., Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Ceva (France) Profile
Table Product Overview
Table Ceva (France) Veterinary-Animal Vaccines Revenue, Gross and Gross Margin (2018-2023)
Figure Ceva (France) Revenue and Growth Rate
Figure Ceva (France) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Cargill, Incorporated (U.S.) Profile
Table Product Overview
Table Cargill, Incorporated (U.S.) Veterinary-Animal Vaccines Revenue, Gross and Gross Margin (2018-2023)
Figure Cargill, Incorporated (U.S.) Revenue and Growth Rate
Figure Cargill, Incorporated (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Boehringer Ingelheim International GmbH. (Germany) Profile
Table Product Overview
Table Boehringer Ingelheim International GmbH. (Germany) Veterinary-Animal Vaccines Revenue, Gross and Gross Margin (2018-2023)
Figure Boehringer Ingelheim International GmbH. (Germany) Revenue and Growth Rate
Figure Boehringer Ingelheim International GmbH. (Germany) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Takeda Pharmaceutical Company Limited (Japan) Profile
Table Product Overview
Table Takeda Pharmaceutical Company Limited (Japan) Veterinary-Animal Vaccines Revenue, Gross and Gross Margin (2018-2023)
Figure Takeda Pharmaceutical Company Limited (Japan) Revenue and Growth Rate
Figure Takeda Pharmaceutical Company Limited (Japan) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Zoetis (U.S.) Profile
Table Product Overview
Table Zoetis (U.S.) Veterinary-Animal Vaccines Revenue, Gross and Gross Margin (2018-2023)
Figure Zoetis (U.S.) Revenue and Growth Rate
Figure Zoetis (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Dechra Pharmaceuticals PLC (U.K.) Profile
Table Product Overview
Table Dechra Pharmaceuticals PLC (U.K.) Veterinary-Animal Vaccines Revenue, Gross and Gross Margin (2018-2023)
Figure Dechra Pharmaceuticals PLC (U.K.) Revenue and Growth Rate
Figure Dechra Pharmaceuticals PLC (U.K.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Hester Biosciences Limited. (India) Profile
Table Product Overview
Table Hester Biosciences Limited. (India) Veterinary-Animal Vaccines Revenue, Gross and Gross Margin (2018-2023)
Figure Hester Biosciences Limited. (India) Revenue and Growth Rate
Figure Hester Biosciences Limited. (India) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Elanco (U.S.) Profile
Table Product Overview
Table Elanco (U.S.) Veterinary-Animal Vaccines Revenue, Gross and Gross Margin (2018-2023)
Figure Elanco (U.S.) Revenue and Growth Rate
Figure Elanco (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Phibro Animal Health Corporation (U.S.) Profile
Table Product Overview
Table Phibro Animal Health Corporation (U.S.) Veterinary-Animal Vaccines Revenue, Gross and Gross Margin (2018-2023)
Figure Phibro Animal Health Corporation (U.S.) Revenue and Growth Rate
Figure Phibro Animal Health Corporation (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Indovax (India) Profile
Table Product Overview
Table Indovax (India) Veterinary-Animal Vaccines Revenue, Gross and Gross Margin (2018-2023)
Figure Indovax (India) Revenue and Growth Rate
Figure Indovax (India) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Global Veterinary-Animal Vaccines Revenue Forecast by Type (2023-2029)
Table Global Veterinary-Animal Vaccines Revenue and Share Forecast by Type (2023-2029)
Table Global Veterinary-Animal Vaccines Revenue by Application (2023-2029)
Table Global Veterinary-Animal Vaccines Revenue and Share by Application (2023-2029)
Figure Global Veterinary-Animal Vaccines Revenue Forecast Market Size (2023-2029)
Table Veterinary-Animal Vaccines Revenue Forecast by Regions (2023-2029)
Table Veterinary-Animal Vaccines Revenue and Share Forecast by Regions (2023-2029)
Figure North America Veterinary-Animal Vaccines Revenue Forecast Market Size (2023-2029)
Figure Europe Veterinary-Animal Vaccines Revenue Forecast Market Size (2023-2029)
Figure Asia-Pacific Veterinary-Animal Vaccines Revenue Forecast Market Size (2023-2029)
Figure Latin America Veterinary-Animal Vaccines Revenue Forecast Market Size (2023-2029)
Figure Middle East & Africa Veterinary-Animal Vaccines Revenue Forecast Market Size (2023-2029)
Table Research Process
Figure Bottom-up and Top-down Approaches for This Report
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|